---
title: "Vir Biotechnology Appoints Marianne De Backer As President In Addition To CEO On March 4, 2026 - SEC Filing"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/277836972.md"
datetime: "2026-03-04T21:43:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/277836972.md)
  - [en](https://longbridge.com/en/news/277836972.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/277836972.md)
---

# Vir Biotechnology Appoints Marianne De Backer As President In Addition To CEO On March 4, 2026 - SEC Filing

March 4 (Reuters) - Vir Biotechnology Inc (VIR.O) : \* VIR BIOTECHNOLOGY INC - APPOINTS MARIANNE DE BACKER AS PRESIDENT IN ADDITION TO CEO ON MARCH 4, 2026 - SEC FILING Source text: Further company coverage: (VIR.O)

### Related Stocks

- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [VIR.US](https://longbridge.com/en/quote/VIR.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)

## Related News & Research

- [Vir Biotechnology announces annual shareholder meeting](https://longbridge.com/en/news/283003484.md)
- [Vir Biotechnology Announces Closing of Global Strategic Collaboration with Astellas for the Treatment of Prostate Cancer | VIR Stock News](https://longbridge.com/en/news/282996089.md)
- [Should Vir’s CMO Exit and Astellas Funding Boost Reshape How Investors View Its R&D Strategy (VIR)?](https://longbridge.com/en/news/282441812.md)
- [Brii Biosciences files arbitration demand against Vir over elebsiran manufacturing transfer](https://longbridge.com/en/news/282972603.md)
- [Liquidia Insider Sold Shares Worth $5,383,388, According to a Recent SEC Filing](https://longbridge.com/en/news/282595697.md)